Nordhealth AS (OSL:NORDH)

Nordhealth AS Statistics

Total Valuation

Nordhealth AS has a market cap or net worth of NOK 2.90 billion. The enterprise value is 2.65 billion.

Market Cap	2.90B
Enterprise Value	2.65B

Important Dates

The last earnings date was Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Nordhealth AS has 79.11 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	44.11M
Shares Outstanding	79.11M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.79%
Owned by Institutions (%)	12.44%
Float	35.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	77.65
PS Ratio	5.01
PB Ratio	3.58
P/TBV Ratio	14.82
P/FCF Ratio	n/a
P/OCF Ratio	53.17
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.83
EV / Sales	4.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-599.98

Financial Position

The company has a current ratio of 2.25

Current Ratio	2.25
Quick Ratio	2.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-298.71

Financial Efficiency

Return on equity (ROE) is -12.79% and return on invested capital (ROIC) is -7.90%.

Return on Equity (ROE)	-12.79%
Return on Assets (ROA)	-6.81%
Return on Invested Capital (ROIC)	-7.90%
Return on Capital Employed (ROCE)	-13.54%
Revenue Per Employee	1.32M
Profits Per Employee	-253,497
Employee Count	411
Asset Turnover	0.57
Inventory Turnover	n/a

Taxes

In the past 12 months, Nordhealth AS has paid 11.93 million in taxes.

Income Tax	11.93M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.98% in the last 52 weeks. The beta is 0.44, so Nordhealth AS's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+3.98%
50-Day Moving Average	37.63
200-Day Moving Average	38.41
Relative Strength Index (RSI)	48.50
Average Volume (20 Days)	6,097

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nordhealth AS had revenue of NOK 578.17 million and -111.29 million in losses. Loss per share was -1.41.

Revenue	578.17M
Gross Profit	186.69M
Operating Income	-110.01M
Pretax Income	-99.36M
Net Income	-111.29M
EBITDA	-54.14M
EBIT	-110.01M
Loss Per Share	-1.41

Balance Sheet

The company has 243.94 million in cash and n/a in debt, giving a net cash position of 243.94 million or 3.08 per share.

Cash & Cash Equivalents	243.94M
Total Debt	n/a
Net Cash	243.94M
Net Cash Per Share	3.08
Equity (Book Value)	809.79M
Book Value Per Share	10.24
Working Capital	184.36M

Cash Flow

In the last 12 months, operating cash flow was 54.46 million and capital expenditures -58.88 million, giving a free cash flow of -4.42 million.

Operating Cash Flow	54.46M
Capital Expenditures	-58.88M
Free Cash Flow	-4.42M
FCF Per Share	-0.06

Margins

Gross margin is 32.29%, with operating and profit margins of -19.03% and -19.25%.

Gross Margin	32.29%
Operating Margin	-19.03%
Pretax Margin	-17.18%
Profit Margin	-19.25%
EBITDA Margin	-9.36%
EBIT Margin	-19.03%
FCF Margin	n/a

Dividends & Yields

Nordhealth AS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	n/a
Earnings Yield	-3.84%
FCF Yield	-0.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nordhealth AS has an Altman Z-Score of 11.6 and a Piotroski F-Score of 4.

Altman Z-Score	11.6
Piotroski F-Score	4